CCIA
PFE icon

Cherry Creek Investment Advisors’s Pfizer PFE Stock Holding History

Cherry Creek Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Buy
24,153
+3,340
+16% +$87.4K 0.23% 66
2026
Q1 		$584K Buy
20,813
+331
+2% +$8.81K 0.25% 60
2025
Q4 		$510K Buy
+20,482
New +$517K 0.22% 67
2023
Q4 		– Sell
-30,920
Closed -$1.03M – 103
2023
Q3 		$1.03M Sell
30,920
-452
-1% -$16K 0.7% 34
2023
Q2 		$1.15M Buy
31,372
+412
+1% +$16K 0.77% 30
2023
Q1 		$1.26M Sell
30,960
-209
-0.7% -$9.03K 0.93% 26
2022
Q4 		$1.6M Buy
31,169
+145
+0.5% +$6.95K 1.24% 21
2022
Q3 		$1.36M Buy
31,024
+266
+0.9% +$12.9K 1.13% 26
2022
Q2 		$1.61M Sell
30,758
-73
-0.2% -$3.72K 1.3% 20
2022
Q1 		$1.6M Sell
30,831
-295
-0.9% -$15.3K 1.05% 27
2021
Q4 		$1.84M Buy
31,126
+648
+2% +$32.1K 1.14% 24
2021
Q3 		$1.31M Buy
30,478
+3,008
+11% +$133K 0.87% 37
2021
Q2 		$1.08M Buy
+27,470
New +$1.07M 0.71% 40

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cherry Creek Investment Advisors's PFE Position: Q2 2026 in Review

Cherry Creek Investment Advisors increased its Pfizer (PFE) stake by 16% in Q2 2026, buying an estimated $87.4K and bringing the position to 24,153 shares worth $582K. The position accounts for 0.23% of the portfolio, ranked #66.

Cherry Creek Investment Advisors first reported a position in PFE in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.84M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cherry Creek Investment Advisors held 24,153 shares of Pfizer worth $582K as of Q2 2026.
  • Cherry Creek Investment Advisors bought 3,340 Pfizer shares in Q2 2026, an estimated $87.4K.
  • Pfizer made up 0.23% of Cherry Creek Investment Advisors's portfolio in Q2 2026, its #66 holding.
  • Cherry Creek Investment Advisors first reported a position in Pfizer in Q2 2021 and has held it in 13 quarters since.
  • Cherry Creek Investment Advisors's Pfizer position peaked at $1.84M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.